Literature DB >> 2003599

Decreased expression of glucose transporter in muscle from insulin-resistant patients.

G L Dohm1, C W Elton, J E Friedman, P F Pilch, W J Pories, S M Atkinson, J F Caro.   

Abstract

We have observed that in vitro incubated human muscle fiber strips from obese patients with or without non-insulin-dependent diabetes mellitus (NIDDM) have reduced insulin-stimulated glucose transport rates compared with nonobese control patients. To investigate if the decrease in glucose transport is associated with a depletion of glucose transport protein, we performed Western blot analysis of muscle samples from nonobese control, obese nondiabetic, and obese NIDDM patients to measure the levels of the muscle-adipose tissue glucose transporter (GLUT-4) protein. Glucose transporter protein was depressed by 23% in the obese nondiabetic and 18% in the obese NIDDM group. The results were essentially the same in the rectus abdominus and vastus lateralis muscles. These data suggest that the decreased glucose transport rate observed in muscle of these obese patients with or without NIDDM may be due, at least in part, to a decreased expression of the "insulin-sensitive" (GLUT-4) glucose transporter. This alteration may play a role in the insulin resistance seen in obesity and diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003599     DOI: 10.1152/ajpendo.1991.260.3.E459

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

Review 1.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes.

Authors:  B B Kahn
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 2.  Effects of exercise training on abdominal obesity and related metabolic complications.

Authors:  B Buemann; A Tremblay
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

Review 3.  The glucose transporter family: structure, function and tissue-specific expression.

Authors:  G W Gould; G D Holman
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

Review 4.  Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension.

Authors:  M B Zemel
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

5.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

Authors:  R C Bonadonna; S Del Prato; M P Saccomani; E Bonora; G Gulli; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 6.  Molecular mechanism of insulin resistance in obesity and type 2 diabetes.

Authors:  Kangduk Choi; Young-Bum Kim
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

7.  Skeletal muscle glucose transporter gene expression is not affected by injecting growth-hormone-secreting cells in young rats.

Authors:  H Imamura; I Morimoto; S Etoh; T Usa; H Namba; A Ohtsuru; A Yokota; S Nagataki; S Yamashita
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

8.  Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Handberg; A Vaag; J Vinten; H Beck-Nielsen
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

9.  Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients.

Authors:  O Schmitz; S Lund; J F Bak; L Orskov; P H Andersen; N Møller; O Rasmussen; J S Christiansen; O Pedersen
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

10.  Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

Authors:  J E Friedman; G L Dohm; N Leggett-Frazier; C W Elton; E B Tapscott; W P Pories; J F Caro
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.